Australian Institute of Health and Welfare
AIHW is Australia’s leading health and welfare statistics agency. Our end-to-end data services ensure strong evidence is available on a wide range of health and welfare matters. This enables stronger decision making for better services and programs for all Australians.
Click on this link to read the most recent report card on Australia’s health
Monash Alfred Psychiatry Research Centre (MAPrc) – 9076 6564
MAPrc is a research centre of Monash University located at Level 4, 607 St Kilda Road,
Melbourne 3004 firstname.lastname@example.org. Getting to MAPrc. The Centre uses advanced neuroscience technology to develop innovative mental health treatments as well as research studying new and improved medications for serious mental illnesses such as schizophrenia, bipolar disorder, major depression and anxiety.
The Florey Institute of Neuroscience and Mental Health, 30 Royal Parade (corner Genetics Lane) Parkville VIC 3052, 9035 3000, email@example.com
The Florey Institute of Neuroscience and Mental Health is the largest brain research group in the Southern Hemisphere. Our teams work on a range of serious diseases including stroke, epilepsy, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, Huntington’s disease, motor neurone disease, traumatic brain and spinal cord injury, depression, schizophrenia, mental illness and addiction. We are world leaders in imaging technology, stroke rehabilitation and epidemiological studies.
Research of the brain and its diseases has gained considerable momentum internationally. Many scientific and technological advancements have been made, and much of our work has been centre stage. Our scientific home is a hive of activity with researchers coming from around the globe to work at the Florey.
State and Federal Governments, major philanthropic foundations and many generous private benefactors have recognised the importance of neuroscience as the final frontier in medical research.
Neuroscience Institute of Schizophrenia and Allied Disorders (NISAD)
NISAD is a non-profit, NHMRC accredited, independent research institute undertaking world-class studies to understand the causes of schizophrenia.
Formed in 1996 and funded by Government, corporate and private donations, it is an innovative “institute without walls” which utilises research and infrastructure facilities located in teaching hospitals, universities and research institutes, as well as domestic and international collaborations, in driving its proactive research agenda.
This means that rather than investing valuable funds in bricks and mortar, efforts are directed at research initiatives to improve the lives of those affected by the disease.
From its central management office currently located within the Garvan Institute of Medical Research in Sydney, NISAD manages and coordinates a multi-disciplinary research program led by scientists of world-standing in their fields, harnessing cutting-edge technology and state-of-the-science techniques.
With some 40 employees and more than 120 scientific affiliates, graduate students and undergraduates, the Institute is committed to achieving its goals through a comprehensive approach combining world-class research, effective management and creative mechanisms to share the vision and attract increased funding to accelerate the scientific program.